• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthDigital Health

Supercharging Philanthropy

By
Clifton Leaf
Clifton Leaf
By
Clifton Leaf
Clifton Leaf
December 15, 2017, 4:45 PM ET

Jonah Comstock at Mobihealthnews.com posted the site’s annual roundup of mergers and acquisitions in the digital health arena today. If you’re looking for where the business appetite is these days, the post makes for instructive reading.

But one of the deals sticks out from the rest: the purchase of Meta by the Chan Zuckerberg Initiative back at the start of the year. Meta—which, in the words of cofounder Sam Molyneux, uses “artificial intelligence to analyze new scientific knowledge as it’s published”—partners with academic journals to access many thousands of scientific papers and draw insight from them (beyond the keywords, that is) with the help of a machine learning tool developed by SRI International, which created Apple’s spectral personal assistant, Siri.

The idea, as we’ve written about many times in this space, is similar to what IBM Watson is doing in oncology and other fields (and what the Allen Institute for Artificial Intelligence’sSemantic Scholar is doing)—and it’s one more reminder of just how integral AI is becoming to healthcare technology.

But it’s also a reminder of something else: of how often philanthropic organizations like CZI are leading the charge today when it comes to championing ambitious new healthcare strategies. Consider Chan Zuckerberg’s Biohub, which is embracing big hairy audacious projects like mapping every cell in the human body (with university partners Berkeley, Stanford, and UCSF) and developing a “universal diagnostic test” and rapid-response team for emerging pathogens.

It’s the same playbook that Sean Parker has been using—and many would say designed—with his Parker Institute for Cancer Immunotherapy. The Bill & Melinda Gates Foundation, meanwhile, has been on the vanguard of no-holds-barred public health campaigns in malaria and HIV—efforts that, to some extent, have helped rewrite the rules of engagement.

For decades, it has seemed, the letters NGO stood for “no go fast.” In the fields of health and medicine, at least, that’s no longer the case.

This essay appears in today’s edition of the Fortune Brainstorm Health Daily. Get it delivered straight to your inbox.

About the Author
By Clifton Leaf
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.